Evidence map›Paper›PMID 39811016›Full record

ReviewRSC advances2025

Exploring the capabilities of 2-alkynyl aryl/benzyl azides: synthesis approaches for indoles, quinolines, and their derivatives

Seyedmohammad Hosseininezhad, Sina Pirani Ahmad Abad, Ali Ramazani

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Seyedmohammad HosseininezhadThe Organic Chemistry Research Laboratory (OCRL), Department of Chemistry, Faculty of Science, University of Zanjan Zanjan 45371-38791 Iran hossinichemistry1397@gmail.com aliramazani@gmail.com aliramazani@znu.ac.ir.
Sina Pirani Ahmad AbadThe Organic Chemistry Research Laboratory (OCRL), Department of Chemistry, Faculty of Science, University of Zanjan Zanjan 45371-38791 Iran hossinichemistry1397@gmail.com aliramazani@gmail.com aliramazani@znu.ac.ir.
Ali RamazaniThe Organic Chemistry Research Laboratory (OCRL), Department of Chemistry, Faculty of Science, University of Zanjan Zanjan 45371-38791 Iran hossinichemistry1397@gmail.com aliramazani@gmail.com aliramazani@znu.ac.ir.ORCID https://orcid.org/0000-0003-3072-7924

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent research, quinoline and indole structures have gained recognition for their significant clinical relevance and effectiveness. These compounds are known for their wide-ranging pharmacological effects, which include anticancer, antibacterial, antifungal, antiviral, and anti-inflammatory properties. Researchers have successfully implemented a variety of innovative synthetic strategies, leading to the creation of numerous compounds that display fascinating biological activities in diverse fields. This has sparked growing interest in developing quinoline and indole-based analogues, given their impressive variety of biological effects. Over the past few years, new, efficient, and more accessible synthetic techniques-such as green chemistry and microwave-assisted synthesis-have been introduced to produce a diverse array of quinoline and indole structures. This development reflects an expanding area of interest in both academic and industrial settings, making it easier to investigate their biological capabilities. In this review, we examine the intriguing transformations of 2-alkynyl aryl and benzyl azide derivatives into indoles and quinolines, emphasizing the role of metal catalysts such as Au, Cu, Rh, Pd, and Ag, from 2011 to 2024. We showcase the variety of substrates involved, highlight notable advancements in this area of research, and address the limitations faced by chemists. Additionally, we offer insights into the mechanisms driving these important reactions, aiming to enhance understanding and inspire future work in this dynamic field.

Identifiers

PMID39811016
PMCPMC11729253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.